Last reviewed · How we verify
Guarana extract
At a glance
| Generic name | Guarana extract |
|---|---|
| Also known as | Paullinia Cupana |
| Sponsor | Faculdade de Medicina do ABC |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effect of a Daily Supplement on Plasma PAI-1 Levels (PHASE1, PHASE2)
- COMP-4 Supplementation and Brachial Artery FMD (PHASE1, PHASE2)
- The Use of Guarana to Treat Fatigue in Patients With Neuroendocrine Tumors and Gynecologic Cancers (Guarana Fatigue) (PHASE2)
- Establishing the Glycaemic Index of Fruit Drinks Using Different Measurement Methodologies (NA)
- "WakeUp" for Vigilance Following Lunch (NA)
- Effect of High-Dose Guarana And Cancer-Related Fatigue (NA)
- A Study to Examine the Effect of a Thermogenic Energy Drink in Healthy Adults (NA)
- Long-term Intervention Effects of a Personalized, Home-based Exercise Program and Nutritional Advice, Along With the Inclusion of a Pre-workout Multi-ingredient Supplement on the Body Composition, Functional Capacity and Quality of Life of Middle-aged and Older Adults (40-70 Years) (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Guarana extract CI brief — competitive landscape report
- Guarana extract updates RSS · CI watch RSS
- Faculdade de Medicina do ABC portfolio CI